According to previous studies [6–9], CD90+ phenotype cells have been considered CSCs in the HCC cell line because of the characteristics of greater colony-forming efficiency in vitro, higher proliferative ability, and greater tumorigenic capacity in vivo when compared to normal HCC cells. The gene discussed is THY1; the disease is hepatocellular carcinoma.